Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545221 - 545240 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 140MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 140MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 140MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 140MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | DASATINIB 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Prasco,LLC |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
Pages
